Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-17

Clinical Trial Update: Homeopathy as an Adjuvant to Chemotherapy Improves Clinical Outcome in Relapsed Pulmonary Tuberculosis [Phase 2]

View source ↗

Summary

A Phase 2 trial reports that using homeopathy as an adjuvant to chemotherapy may improve clinical outcomes in relapsed pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chemotherapy (unspecified regimen)
  • Homeopathy

Snippet

Sponsor: NMP Medical Research Institute | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED